DFTX
NASDAQ · Pharmaceuticals
Definium Therapeutics Inc
$17.79
-0.31 (-1.71%)
Open$17.99
Previous Close$18.10
Day High$18.10
Day Low$17.25
52W High$18.70
52W Low$14.62
Volume—
Avg Volume1.33M
Market Cap1.70B
P/E Ratio—
EPS$-1.97
SectorPharmaceuticals
Analyst Ratings
Strong Buy
21 analysts
Price Target
+158.6% upside
Current
$17.79
$17.79
Target
$46.00
$46.00
$39.37
$46.00 avg
$57.04
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 685.27M | 628.04M | 535.94M |
| Net Income | 136.42M | 119.21M | 84.03M |
| Profit Margin | 19.9% | 19.0% | 15.7% |
| EBITDA | 222.00M | 198.31M | 161.40M |
| Free Cash Flow | 100.39M | 95.21M | 82.42M |
| Rev Growth | -7.8% | +7.1% | -9.9% |
| Debt/Equity | 0.71 | 0.57 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |